Ionis Pharmaceuticals Inc. Common Stock vs Stellantis N.V. Common Shares — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Stellantis N.V. Common Shares trades at $4.3 (market cap $16.51B). The key difference: Stellantis N.V. Common Shares is far larger — about 2.3× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Stellantis N.V. Common Shares is more actively traded (28,274,156 versus 2,977,440). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.
| IONS | STLA | |
|---|---|---|
Market Cap | $7.04B | $16.51B |
Volume | 2,977,440 | 28,274,156 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $12.12 |
52-Week Low | $42.38 | $4.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $36.19B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →